These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 18703779)

  • 1. Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure.
    Panchatcharam M; Miriyala S; Yang F; Rojas M; End C; Vallant C; Dong A; Lynch K; Chun J; Morris AJ; Smyth SS
    Circ Res; 2008 Sep; 103(6):662-70. PubMed ID: 18703779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.
    Hao F; Zhang F; Wu DD; An D; Shi J; Li G; Xu X; Cui MZ
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C975-C984. PubMed ID: 27760754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.
    Zhao Y; Tong J; He D; Pendyala S; Evgeny B; Chun J; Sperling AI; Natarajan V
    Respir Res; 2009 Nov; 10(1):114. PubMed ID: 19930563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential targeting of lysophosphatidic acid LPA
    Olianas MC; Dedoni S; Onali P
    Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
    Chen M; Towers LN; O'Connor KL
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation.
    Subramanian P; Karshovska E; Reinhard P; Megens RT; Zhou Z; Akhtar S; Schumann U; Li X; van Zandvoort M; Ludin C; Weber C; Schober A
    Circ Res; 2010 Jul; 107(1):96-105. PubMed ID: 20360252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPA
    Dancs PT; Ruisanchez É; Balogh A; Panta CR; Miklós Z; Nüsing RM; Aoki J; Chun J; Offermanns S; Tigyi G; Benyó Z
    FASEB J; 2017 Apr; 31(4):1547-1555. PubMed ID: 28069828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
    Kim J; Keys JR; Eckhart AD
    Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
    Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matricellular protein Cyr61 bridges lysophosphatidic acid and integrin pathways leading to cell migration.
    Wu DD; Zhang F; Hao F; Chun J; Xu X; Cui MZ
    J Biol Chem; 2014 Feb; 289(9):5774-83. PubMed ID: 24371135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
    Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
    J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lysophosphatidic acid: a "bioactive" phospholipid].
    Saulnier-Blache JS
    Med Sci (Paris); 2004; 20(8-9):799-803. PubMed ID: 15361348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPA
    Wang F; Liu S; Pei J; Cai L; Liu N; Liang T; Dong X; Cong X; Chun J; Chen J; Hu S; Chen X
    Theranostics; 2020; 10(24):10892-10907. PubMed ID: 33042260
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells.
    Shin KJ; Kim YL; Lee S; Kim DK; Ahn C; Chung J; Seong JY; Hwang JI
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):45-52. PubMed ID: 18592268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.
    Cheng Y; Makarova N; Tsukahara R; Guo H; Shuyu E; Farrar P; Balazs L; Zhang C; Tigyi G
    Cell Signal; 2009 Dec; 21(12):1874-84. PubMed ID: 19709640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells.
    Zhou Z; Niu J; Zhang Z
    Mol Biol Rep; 2010 Jul; 37(6):2675-86. PubMed ID: 19757175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.
    Shida D; Watanabe T; Aoki J; Hama K; Kitayama J; Sonoda H; Kishi Y; Yamaguchi H; Sasaki S; Sako A; Konishi T; Arai H; Nagawa H
    Lab Invest; 2004 Oct; 84(10):1352-62. PubMed ID: 15220934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A blocking peptide stabilizes lysophosphatidic acid receptor 1 and promotes lysophosphatidic acid-induced cellular responses.
    Taleb SJ; Wei J; Mialki RK; Dong S; Li Y; Zhao J; Zhao Y
    J Cell Biochem; 2021 Aug; 122(8):827-834. PubMed ID: 33847006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid.
    Guo H; Makarova N; Cheng Y; E S; Ji RR; Zhang C; Farrar P; Tigyi G
    Biochim Biophys Acta; 2008 Sep; 1781(9):571-81. PubMed ID: 18602022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.